{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "37992028",
  "DateCompleted": {
    "Year": "2023",
    "Month": "11",
    "Day": "27"
  },
  "DateRevised": {
    "Year": "2023",
    "Month": "11",
    "Day": "27"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2023",
        "Month": "11",
        "Day": "22"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "e0293774",
      "10.1371/journal.pone.0293774"
    ],
    "Journal": {
      "ISSN": "1932-6203",
      "JournalIssue": {
        "Volume": "18",
        "Issue": "11",
        "PubDate": {
          "Year": "2023"
        }
      },
      "Title": "PloS one",
      "ISOAbbreviation": "PLoS One"
    },
    "ArticleTitle": "Investigating the impact of physical activity on mitochondrial function in Parkinson's disease (PARKEX): Study protocol for A randomized controlled clinical trial.",
    "Pagination": {
      "StartPage": "e0293774",
      "MedlinePgn": "e0293774"
    },
    "Abstract": {
      "AbstractText": [
        "Parkinson's disease (PD) is characterized by the progressive dopaminergic neuron degeneration, resulting in striatal dopamine deficiency. Mitochondrial dysfunction and oxidative stress are associated with PD pathogenesis. Physical activity (PA) has been shown to ameliorate neurological impairments and to impede age-related neuronal loss. In addition, skin fibroblasts have been identified as surrogate indicators of pathogenic processes correlating with clinical measures. The PARKEX study aims to compare the effects of two different PA programs, analyzing the impact on mitochondrial function in patients' skin fibroblasts as biomarkers for disease status and metabolic improvement. Early-stage PD patients (n = 24, H&Y stage I to III) will be randomized into three age- and sex-matched groups. Group 1 (n = 8) will undergo basic physical training (BPT) emphasizing strength and resistance. Group 2 (n = 8) will undergo BPT combined with functional exercises (BPTFE), targeting the sensorimotor pathways that are most affected in PD (proprioception-balance-coordination) together with cognitive and motor training (Dual task training). Group 3 (n = 8) will serve as control (sedentary group; Sed). Participants will perform three sessions per week for 12 weeks. Assessment of motor function, quality of life, sleep quality, cognitive aspects and humor will be conducted pre- and post-intervention. Patient skin fibroblasts will be collected before and after the intervention and characterized in terms of metabolic remodeling and mitochondrial bioenergetics. Ethical approval has been given to commence this study. This trial is registered at clinicaltrials.gov (NCT05963425). Trial registration. https://classic.clinicaltrials.gov/ct2/history/NCT05963425."
      ],
      "CopyrightInformation": "Copyright: \u00a9 2023 Maga\u00f1a et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited."
    },
    "AuthorList": [
      {
        "Identifier": [
          "0000-0002-3842-092X"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Facultat de Psicologia, Ci\u00e8ncies de l'Educaci\u00f3 i de l'Esport Blanquerna, Ramon Llull University, Barcelona, Spain."
          }
        ],
        "LastName": "Maga\u00f1a",
        "ForeName": "Juan Carlos",
        "Initials": "JC"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "CNC-UC, Center for Neuroscience and Cell Biology, University of Coimbra, Coimbra, Portugal."
          },
          {
            "Identifier": [],
            "Affiliation": "CIBB, Center for Innovative Biomedicine and Biotechnology, University of Coimbra, Coimbra, Portugal."
          }
        ],
        "LastName": "Deus",
        "ForeName": "Cl\u00e1udia Maria",
        "Initials": "CM"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Facultat de Ci\u00e8ncies de la Salut, Blanquerna, Ramon Llull University, Barcelona, Spain."
          }
        ],
        "LastName": "Baldellou",
        "ForeName": "Laura",
        "Initials": "L"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Hospital Nostra Senyora de Meritxell, Escaldes-Engordany, Andorra."
          },
          {
            "Identifier": [],
            "Affiliation": "Universitat d'Andorra, Sant Juli\u00e0 de L\u00f2ria, Andorra."
          }
        ],
        "LastName": "Avellanet",
        "ForeName": "Merce",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Hospital Nostra Senyora de Meritxell, Escaldes-Engordany, Andorra."
          },
          {
            "Identifier": [],
            "Affiliation": "Universitat d'Andorra, Sant Juli\u00e0 de L\u00f2ria, Andorra."
          }
        ],
        "LastName": "Gea-Rodr\u00edguez",
        "ForeName": "Elvira",
        "Initials": "E"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Grup de Malalties Neurodegeneratives de la Vall d'Hebron. Vall d'Hebron Institut de Recerca (VHIR), Barcelona, Spain."
          }
        ],
        "LastName": "Enriquez-Calzada",
        "ForeName": "Silvia",
        "Initials": "S"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Grup de Malalties Neurodegeneratives de la Vall d'Hebron. Vall d'Hebron Institut de Recerca (VHIR), Barcelona, Spain."
          },
          {
            "Identifier": [],
            "Affiliation": "Aligning Science Across Parkinson's (ASAP) Collaborative Research Network, Chevy Chase, MD, United States of America."
          },
          {
            "Identifier": [],
            "Affiliation": "Institut de Neuroci\u00e8ncies-Autonomous University of Barcelona (INc-UAB), Cerdanyola del Vall\u00e8s, Spain."
          }
        ],
        "LastName": "Laguna",
        "ForeName": "Ariadna",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Grup de Malalties Neurodegeneratives de la Vall d'Hebron. Vall d'Hebron Institut de Recerca (VHIR), Barcelona, Spain."
          }
        ],
        "LastName": "Mart\u00ednez-Vicente",
        "ForeName": "Marta",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Grup de Malalties Neurodegeneratives de la Vall d'Hebron. Vall d'Hebron Institut de Recerca (VHIR), Barcelona, Spain."
          }
        ],
        "LastName": "Hern\u00e1ndez-Vara",
        "ForeName": "Jorge",
        "Initials": "J"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Facultat de Psicologia, Ci\u00e8ncies de l'Educaci\u00f3 i de l'Esport Blanquerna, Ramon Llull University, Barcelona, Spain."
          },
          {
            "Identifier": [],
            "Affiliation": "Facultat de Ci\u00e8ncies de la Salut, Blanquerna, Ramon Llull University, Barcelona, Spain."
          }
        ],
        "LastName": "Gin\u00e9-Garriga",
        "ForeName": "Maria",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "CNC-UC, Center for Neuroscience and Cell Biology, University of Coimbra, Coimbra, Portugal."
          },
          {
            "Identifier": [],
            "Affiliation": "CIBB, Center for Innovative Biomedicine and Biotechnology, University of Coimbra, Coimbra, Portugal."
          },
          {
            "Identifier": [],
            "Affiliation": "Faculty of Sports, Laboratory of Metabolism and Exercise (LaMetEx), Research Centre in Physical Activity, Health and Leisure (CIAFEL), Laboratory for Integrative and Translational Research in Population Health (ITR), University of Porto, Porto, Portugal."
          }
        ],
        "LastName": "Pereira",
        "ForeName": "Susana Patricia",
        "Initials": "SP"
      },
      {
        "Identifier": [
          "0000-0001-9531-9580"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Facultat de Psicologia, Ci\u00e8ncies de l'Educaci\u00f3 i de l'Esport Blanquerna, Ramon Llull University, Barcelona, Spain."
          },
          {
            "Identifier": [],
            "Affiliation": "Facultat de Ci\u00e8ncies de la Salut, Blanquerna, Ramon Llull University, Barcelona, Spain."
          }
        ],
        "LastName": "Montane",
        "ForeName": "Joel",
        "Initials": "J"
      }
    ],
    "DataBankList": [
      {
        "DataBankName": "ClinicalTrials.gov",
        "AccessionNumberList": [
          "NCT05963425"
        ]
      }
    ],
    "PublicationTypeList": [
      "Clinical Trial Protocol",
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "PLoS One",
    "NlmUniqueID": "101285081",
    "ISSNLinking": "1932-6203"
  },
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Quality of Life"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Parkinson Disease"
    },
    {
      "QualifierName": [
        "methods"
      ],
      "DescriptorName": "Exercise Therapy"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Research Design"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Exercise"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Randomized Controlled Trials as Topic"
    }
  ],
  "CoiStatement": "No potential conflict of interest was reported by the authors."
}